Postmarketing Drug Safety Surveillance: An Overview of Regulatory Issues

By Wu J.H.  

Pharmaceutical Development and Regulation, Vol. 1, Iss. 4, 2003-01 ,pp. : 231-244

Adis International

Access to resources Recommend Favorite

A Pharmacoepidemiological Network Model for Drug Safety Surveillance: Statins and Rhabdomyolysis

By Reis Ben Y.  

Drug Safety, Vol. 35, Iss. 5, 2012-05 ,pp. : 395-406

Adis International

Access to resources Recommend Favorite

Improving Drug Safety: Active Surveillance Systems Should be Paramount

By McClure David L.  

Pharmaceutical Medicine, Vol. 23, Iss. 3, 2009-06 ,pp. : 127-130

Adis International

Access to resources Recommend Favorite

Health-insurance-claims databases may be able to be used for drug-safety surveillance

By  

Reactions Weekly, Vol. 1, Iss. 1287, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Data Mining in Drug Safety: Review of Published Threshold Criteria for Defining Signals of Disproportionate Reporting

By Deshpande Gaurav  

Pharmaceutical Medicine, Vol. 24, Iss. 1, 2010-02 ,pp. : 37-43

Adis International

Access to resources Recommend Favorite